Once considered junk, cellular 'chimeras' emerge as key to better cancer care
UVA Comprehensive Cancer Center researchers have found an answer to one of the great mysteries of human biology, and the discovery could have major implications for the battle against breast cancer and other diseases.
Researchers at the University of Virginia have identified a previously overlooked component of human biology that could significantly impact cancer treatment. Traditionally dismissed as cellular "junk," chimeric RNA molecules are now recognized as essential genetic instructions that expand our cellular blueprints beyond traditional genes.
UVA's Hui Li, Ph.D., discovered that these RNA fragments, which combine genetic material from multiple genes, can perform vital functions in healthy cells. Contrary to earlier assumptions that these RNA molecules were mere mistakes or solely cancer-associated, Li and his team found that chimeric RNAs are widespread in all human tissues and play crucial roles in both healthy cells and disease.
Their research published in Science Advances reveals that faulty chimeric RNAs are often implicated in breast cancer development. The scientists created an atlas cataloging over 569,000 chimeric RNAs across 1,019 cancer cell lines, demonstrating that these RNA molecules have essential functions in cellular health and contribute to various diseases.
The findings suggest that targeting malfunctioning chimeras could lead to novel cancer therapies. Li emphasizes the vast potential of this new biological layer, encouraging researchers to explore the implications of chimeric RNAs for future cancer care advancements.
Written by urgent.news from Medical Xpress's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
